TD Asset Management Inc. Lowers Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

TD Asset Management Inc. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 461,639 shares of the medical equipment provider's stock after selling 6,226 shares during the quarter. TD Asset Management Inc. owned approximately 0.13% of Intuitive Surgical worth $240,957,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ISRG. Proficio Capital Partners LLC boosted its position in Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock valued at $495,845,000 after purchasing an additional 948,902 shares in the last quarter. FMR LLC raised its holdings in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $313,769,000. Wilmington Savings Fund Society FSB boosted its holdings in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock valued at $272,980,000 after buying an additional 552,058 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in shares of Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Remove Ads

Intuitive Surgical Trading Down 3.2 %

ISRG traded down $16.06 during midday trading on Friday, hitting $491.84. 1,966,546 shares of the company traded hands, compared to its average volume of 1,527,047. The business has a 50 day simple moving average of $556.28 and a two-hundred day simple moving average of $532.68. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The company has a market capitalization of $175.18 billion, a price-to-earnings ratio of 76.73, a PEG ratio of 5.85 and a beta of 1.43.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 in the last 90 days. Insiders own 0.90% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on ISRG shares. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Barclays raised their price objective on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Finally, Leerink Partners upped their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.